{
    "Ingredient": "FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE",
    "DF;Route": "POWDER;INHALATION",
    "Trade_Name": "TRELEGY ELLIPTA",
    "Applicant": "GLAXOSMITHKLINE",
    "Strength": "0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH",
    "Appl_Type": "N",
    "Appl_No": 209482,
    "Product_No": 2,
    "TE_Code": null,
    "Approval_Date": "Sep 9, 2020",
    "RLD": "Yes",
    "RS": "Yes",
    "Type": "RX",
    "Applicant_Full_Name": "GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND"
}